Share your experiences with COVID-19, get access to participate in clinical research, and contribute to the growing knowledge base about how we can fight COVID-19 together. ACCESS is a multi-company research initiative designed to accelerate development of diagnostics, treatments and vaccines for COVID-19. Participants will receive periodic surveys, information resources and opt-in access to clinical trials. Participation is limited to United States residents age 18 or above.